SOX2 and cervical carcinoma: Also, overexpression of FAP1-AS1 had no statistical impact on cervical cancer cell stemness, as shown by no statistical difference in the level of NANOG and SOX2 between the control group and the overexpressed AFAP1-AS1 group (Fig. S1B).